ARN22089 | MedChemExpress (MCE)

ARN22089 is a oral active novel class of trisubstituted pyrimidine, blocks the interaction of CDC42 GTPases with specific downstream effectors. ARN22089 blocks tumor growth in BRAF mutant mouse melanoma model[1].

Trivial name ARN22089
Catalog Number HY-149464
Research Area Cancer
CAS# 2248691-29-2
Purity 98.2%
SMILES CN(C)C1=CC(NC2=CC(C3=CC=CC=C3)=NC(C4CCNCC4)=N2)=CC=C1
Size 5 mg
Supplier Page https://www.medchemexpress.com/arn22089.html